Elevance Health raises guidance. Elevance Health stock has USD 95.4 billion in value
Published on 10/26/2026 at 12:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance and dates
- Adjusted diluted earnings per share guidance reached at least USD 29.00 for fiscal year 2026 on October 21, 2026.
- BofA raised its Elevance Health target from USD 480.00 to USD 500.00 on October 22, 2026.
- Elevance Health stock trades at EUR 394.30 at 12:15 p.m. CET at Lang & Schwarz on October 26, 2026.
- The fourth-quarter dividend of USD 1.72 per share is payable on December 18, 2026.
Elevance Health (ISIN US0367521038) was trading at EUR 394.30 at Lang & Schwarz on October 26, 2026 at 12:15 p.m. CET, alongside a USD 95.4 billion market value as of October 23, 2026. The health insurer raised its fiscal 2026 adjusted diluted earnings per share guidance to at least USD 29.00 after reporting third-quarter revenue of USD 50.4 billion, according to Elevance Health on October 21, 2026.
Third-quarter figures reset guidance
The third-quarter revenue figure increased 0.7 percent from the prior-year quarter. Adjusted diluted earnings per share reached USD 6.99, while the GAAP figure was USD 6.27, with the company citing a USD 1.85 per-share net non-operating benefit.
The benefit expense ratio improved 70 basis points to 90.6 percent in the third quarter of 2026. That improvement supported the higher outlook, although medical membership fell by 487,000 year over year to approximately 44.9 million as of September 30, 2026.
Three dated developments
On October 20, 2026, Elevance Health declared a fourth-quarter dividend of USD 1.72 per share, according to Elevance Health. On October 21, 2026, it reported USD 50.4 billion in third-quarter operating revenue and lifted adjusted earnings guidance to at least USD 29.00. On October 22, 2026, BofA analyst Kevin Fischbeck raised the price target from USD 480.00 to USD 500.00 while maintaining a Buy rating, as Markets Insider reported.
What dates matter next?
The next dated cash event is the December 4, 2026 record date for the dividend, followed by the December 18, 2026 payment date. Both dates were specified in the October 21 release from Elevance Health.
Stock valuation remains the market anchor
Elevance Health trades on the NYSE under the ticker ELV. Its USD 274.84 to USD 450.69 52-week range, measured as of October 23, 2026, places the latest US-market reference near the upper end of the annual span, while the euro quote reflects the German trading perspective.
Guidance now sets the tone
Management also raised fiscal 2026 operating cash flow guidance to at least USD 6.5 billion. Carelon generated USD 19.3 billion in third-quarter revenue, up 5 percent year over year, and operating gain rose 17 percent to USD 0.9 billion. The combination of higher guidance and stronger Carelon performance gives the stock a concrete earnings anchor, while membership trends remain a key operating variable.
The further course of trading is shown by the continuously updated real-time quote of Elevance Health stock.
Elevance Health stock facts
- Company: Elevance Health Inc.
- ISIN: US0367521038
- Ticker: ELV
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 26, 2026, 12:15 p.m. CET): EUR 394.30
- Market capitalization: USD 95.4 billion (as of October 23, 2026)
- 52-week range: USD 274.84-450.69 (as of October 23, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
- Index membership: S&P 500
Market context: Market report S&P 500.
